On Dec 12, 2025, Paul Oladele and Timothy A. Johnson from the Department of Animal Sciences, Purdue University, published an article in the journal ISME Communications entitled "Trehalose and maltodextrin preserve microbial community structure in freeze-dried fecal samples for fecal microbiota transplantation." The paper addresses a critical bottleneck in carbohydrate-mediated biopreservation, investigating how different lyoprotectants, specifically mannitol, maltodextrin, and trehalose, impact the viability and ecological integrity of complex microbial communities during the freeze-drying (lyophilization) process. By utilizing propidium monoazide (PMA) treatment combined with 16S rRNA sequencing (PMA-seq), the study reveals that trehalose and maltodextrin are superior to mannitol in maintaining the "viable" community structure. This ensures that fecal microbiota transplantation (FMT) inocula remain biologically effective and taxonomically representative post-processing, marking a significant advancement in the manufacturing of shelf-stable microbiome therapeutics.

Fig.1 Trehalose and maltodextrin preserve microbial community structure in freeze-dried fecal samples. (Oladele & Johnson, 2025)

The Carbohydrate Shield: Mechanics of Lyoprotection in Microbial Ecosystems

As a carbohydrate manufacturing expert with decades of experience, CD BioGlyco has seen the evolution of stabilization techniques, but the challenge of preserving an entire ecosystem rather than a single strain is where the true complexity lies. Fecal microbiota transplantation (FMT) has transitioned from an experimental procedure to a cornerstone therapy for Clostridioides difficile infections and a burgeoning field for treating metabolic and neurodegenerative disorders. However, the reliance on fresh fecal matter presents logistical nightmares, including strict timing requirements and the inability to perform pathogen screening before administration.

Lyophilization offers a solution by converting these communities into stable, storable powders. But the process is inherently destructive. During freezing, water removal causes the cell membrane to transition from a liquid-crystalline state to a rigid gel phase, leading to leakage and death. Carbohydrate lyoprotectants act as "water substitutes." They form hydrogen bonds with the polar head groups of lipids, maintaining membrane fluidity even in the absence of water.

The choice of carbohydrate is governed by its physical chemistry. While simple sugars like mannitol (a monosaccharide) are often used, their tendency to crystallize during the freeze-drying process often compromises their protective efficiency. In contrast, disaccharides like trehalose and polysaccharides like maltodextrin are renowned for their ability to form stable, amorphous "glassy" matrices that encapsulate and protect delicate biological structures without the jagged edges of ice crystals.

Comparative Viability Assay: Measuring the "Life" Post-Lyophilization

The experimental design focused on 12-week-old pig fecal samples, which serve as an excellent model for complex anaerobic communities. These samples were treated with 5% solutions of mannitol, maltodextrin, trehalose, or a 1:1 maltodextrin-trehalose blend. The researchers utilized the QUANTOM Tx Microbial Automated Cell Counter to distinguish between total and viable cells using membrane-permeable and impermeable fluorescent dyes.

• Experimental Result: While all lyoprotectants improved survival compared to the PBS control, trehalose and maltodextrin outperformed mannitol. Samples preserved with trehalose maintained a higher concentration of viable cells, proving that the molecular structure of the carbohydrate directly correlates with the survival rate of the fecal slurry.
• Innovation: The study demonstrates that "survival" is not binary across an entire community. Trehalose's high degree of hydration and hydrogen-bonding capacity allows for a much higher recovery of metabolically active units compared to the crystalline structure of mannitol.

Fig.2 Effect of lyoprotectant on total bacterial count, viable bacterial count, observed number of ASVs, Pielou evenness, and Faith's phylogenetic diversity. (Oladele & Johnson, 2025)

PMA-seq Implementation: Distinguishing the Living from the Dead

A common pitfall in microbial analysis is that DNA sequencing detects both live and dead bacteria indiscriminately. This is a major hurdle for carbohydrate manufacturers who need to prove their product is "active." To solve this, the authors employed PMA treatment. PMA is a dye that only enters cells with compromised membranes (the dead). Once inside, it intercalates into the DNA and, upon exposure to light, forms a covalent bond that prevents that DNA from being amplified during sequencing.

• Experimental Result: The results were staggering. In the "Total Community" analysis (without PMA), the microbial profiles looked almost identical across all treatment groups. However, when looking at the "Viable Community" (PMA-treated), it became clear that mannitol treatment led to a significant loss of alpha diversity and a dramatic shift in community structure.
• Innovation: This methodology proves that traditional metagenomics may hide the damage caused by poor manufacturing processes. The innovation lies in using PMA-seq as a high-resolution quality control tool to validate the protective efficacy of carbohydrates.

Taxon-Specific Sensitivity: Vulnerability of Gram-Negative Bacteria

The study observed how different phyla responded to the extreme stress of freeze-drying. Gram-negative bacteria, which include many beneficial but fragile species, are characterized by their thinner peptidoglycan layer and an outer membrane, making them more sensitive to lyophilization than Gram-positive bacteria.

• Experimental Result: Trehalose and maltodextrin were specifically effective at shielding these sensitive Gram-negative taxa. In contrast, mannitol-treated samples saw an artificial "enrichment" of certain Gram-positive genera (like Corynebacterium). This wasn't because these bacteria grew; it was because the other, more sensitive bacteria died off, skewing the relative abundance.
• Innovation: This emphasizes that lyoprotectant choice inadvertently "edits" the microbiome's composition. For a manufacturer, maintaining the donor's original "taxonomic fingerprint" is crucial, and this study provides the evidence that disaccharides and polysaccharides are necessary to achieve that fidelity.

Discussion and Innovations

• The Superiority of Glass-Forming Amorphous Sugars
  From a technical standpoint, the most significant innovation is the validation of trehalose and maltodextrin's physical properties in a fecal matrix. Trehalose possesses an exceptionally high glass transition temperature (Tg), meaning it remains in a protective, non-crystalline state even if there are slight temperature fluctuations during storage. Maltodextrin, being a glucose polymer, provides structural bulk and prevents the "stickiness" often seen in high-viscosity cryoprotectants like glycerol. This study confirms that these physical attributes translate directly into superior ecological preservation.
• Debunking the Synergy Myth for Fecal Slurries
  Interestingly, while some literature suggests a synergy between disaccharides and polysaccharides, this study found that the 1:1 mixture of maltodextrin and trehalose performed similarly to individual treatments but actually caused a slightly higher depletion of certain microbial taxa. This is a vital discovery for carbohydrate manufacturers: "more" is not always "better." Precision in formulation, choosing a single, high-performing carbohydrate like trehalose, may be more beneficial for community integrity than complex mixtures that might interfere with one another at the molecular level.

Oligosaccharide Manufacture Service at CD BioGlyco

Leveraging state-of-the-art enzymatic synthesis and sophisticated purification platforms, CD BioGlyco provides tailor-made carbohydrate solutions that meet the stringent oligosaccharide manufacturing needs. Whether you are optimizing a specific oligosaccharide formulation or requiring high-purity oligosaccharides for perclinical-grade lyophilization, our expertise ensures that the manufacture is robust, scalable, and compliant with global manufacturing standards. By integrating such specialized manufacturing services, the transition from research idea to effective project becomes a streamlined reality.

Conclusion

This research provides a rigorous scientific roadmap for the industrial-scale manufacturing of stable, freeze-dried microbial therapies. By demonstrating that trehalose and maltodextrin are the gold standards for preserving not just the quantity, but the taxonomic quality of viable bacteria, Oladele and Johnson have bridged the gap between carbohydrate chemistry and clinical FMT efficacy.

For professionals in the field, the takeaway is clear: the choice of carbohydrate excipient is a primary determinant of a product's biological identity. We are moving away from "black box" preservation towards a future where we maintain the delicate balance of the gut ecosystem through advanced glycobiology. The integration of PMA-seq into our manufacturing and quality control protocols will be vital for ensuring that "shelf-stable" truly means "therapeutically active" for the patients who need it most.